van Zelst, Cathelijne M.
Goossens, Lucas M. A.
Witte, Jan A.
Braunstahl, Gert-Jan
Hendriks, Rudi W.
Rutten-van Molken, Maureen P. M. H.
Veen, Johannes C. C. M. in’t
Funding for this research was provided by:
Teva Pharmaceutical Industries
Chiesi Farmaceutici
Boehringer Ingelheim
AstraZeneca Foundation
Article History
Received: 18 March 2022
Accepted: 19 November 2022
First Online: 9 December 2022
Declarations
:
: This study was performed after approval by the Institutional Research Board of the Franciscus Gasthuis en Vlietland, Rotterdam, the Netherlands. This research was declared as outside the scope of the Medical Research Involving Human Subjects Act, because routinely collected health care data were used after pseudonymization. This waives the requirement to obtain informed consent.
: Not applicable.
: CZ: No competing interests related to the topic. LG: No competing interests related to the topic. AW: No competing interests related to the topic. GB: No competing interests related to the topic. RH: No competing interests related to the topic. MR: No competing interests related to the topic. JV: No competing interests related to the topic.